The Hormone market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include Novo Nordisk Pfizer Eli Lilly Merck Serono F. Hoffmann-La Roche Ferring Pharmaceuticals GeneScience Pharmaceuticals Ipsen LG Life Sciences Sandoz International Anhui Anke Biotechnology This report with sales, revenue and market share for each type, split by product types/category, covering Powder Solvent This report focuses on sales, market share and growth rate of Hormone in each application, split by applications/end use industries, covers Growth Hormone Deficiency (GHD) Turner Syndrome Chronic Renal Insufficiency Prader Willi Syndrome Small for Gestational Age SHOX Deficiency Other
Table of Contents 2017-2022 United States Hormone Market Report (Status and Outlook) 1 Hormone Market Overview 1.1 Product Overview and Scope of Hormone 1.2 Hormone Market Segment by Types 1.2.1 United States Hormone Sales Present Situation and Outlook by Types (2012-2022) 1.2.2 United States Hormone Sales Market Share by Types in 2016 1.2.3 Powder
